Skip to main content

Google and GSK just had a baby company — Galvani Bioelectronics

10 years from now - how will we fight disease?
Google has conceived and given life to another corporate child, and this time, it’s co-parent is GlaxoSmithKline. On Tuesday, the internet giant (or more specifically, Verily, which used to be known as Google Life Sciences) and the pharmaceutical heavyweight announced the creation of a brand new venture known as Galvani Bioelectronics, a firm that seeks to “enable the research, development, and commercialization of bioelectronic medicines.”

What is bioelectronic medicine, you ask? The rather new field makes use of miniature, implantable devices that modify electric signals sent through our nervous system, with the hope of addressing a number of chronic diseases. For the last four years, GSK researchers have been active in this field, and the formation of Galvani Bioelectronics heralds a crucial step forward in their efforts.

“Bioelectronic medicine’s vision is to employ the latest advances in biology and technology to interpret this electrical conversation and to correct the irregular patterns found in disease states, using miniaturized devices attached to individual nerves,” said Moncef Slaoui, GSK’s Chairman of Global Vaccines. “If successful, this approach offers the potential for a new therapeutic modality alongside traditional medicines and vaccines.”

By combining GSK’s expertise in pharmaceuticals and disease biology with Verily’s knowledge of technology and device development, the two companies hope to establish “clinical proofs of principle in inflammatory, metabolic and endocrine disorders, including type 2 diabetes … and [develop] associated miniaturized, precision devices.”

Brian Otis, Verily’s chief technology officer, noted, “This is an ambitious collaboration allowing GSK and Verily to combine forces and have a huge impact on an emerging field. Bioelectronic medicine is a new area of therapeutic exploration, and we know that success will require the confluence of deep disease biology expertise and new highly miniaturized technologies.”

The two parent companies have committed to investing up to $715 million over the next seven years, and hope to have treatments prepared for approval by 2023.

“This agreement with Verily to establish Galvani Bioelectronics signals a crucial step forward in GSK’s bioelectronics journey,” Slaoui concluded. “Together, we can rapidly accelerate the pace of progress in this exciting field, to develop innovative medicines that truly speak the electrical language of the body.”

Editors' Recommendations

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
The best new Chromebook features that Google just announced
lenovo thinkpad c13 yoga chromebook review enterprise

Google is celebrating the 10th birthday of its Chrome OS operating system in style. Chromebook owners will be getting a big set of new features to mark the miestone, including a "Phone Hub" that will bring Android phones closer to Chrome OS, as well as a new built-in screen recorder.

According to Google, these new features are all designed to help people get things done, as well as "provide a simple computing experience to people who use Chromebooks." With most new features coming in Chrome OS version 89, Google also hopes the features will "entertain [people] while they unwind."

Read more
Google revenues drop for first time in the company’s history
Google Logo

Google’s parent company Alphabet reported the first revenue decline in the company’s 22-year history when it released its Q2 earnings on Thursday.

During the second quarter of this year, Alphabet made $38.3 billion in revenue, compared to $38.9 billion during the same time last year, which is a 2% decrease. Chief Financial Officer of Alphabet and Google, Ruth Porat, said in the earnings call that a gradual improvement in advertising largely drove revenue. 

Read more
Google employees demand the company cancel all police contracts
Google Logo

More than 1,600 workers at Google have put their name to a letter to CEO Sundar Pichai demanding that the company stop selling its products and technology to police departments.

The move comes amid growing calls for police reform as part of efforts to tackle systemic racism.

Read more